Tag: ROS1 Inhibitor
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib?ROS1 Inhibitor) are Published...
Innovent Biologics Reveals Breakthrough Data from Phase 2 TRUST-I Study of Taletrectinib at 2024 ASCO Annual MeetingSAN FRANCISCO, U.S. and SUZHOU, China - Innovent...